SEARCH RESULTS FOR: "Tag: SAGE"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2020(1)
2019(5)
2018(5)
2017(6)
2016(5)
2015(3)
CATEGORIES
Analyst Update(3)
Buzz Stocks(8)
By the Numbers(1)
Earnings Preview(1)
Expectational Analysis(1)
General(1)
Indexes and ETFs(1)
Midday Market Check(2)
Opening View(3)
Quantitative Analysis(2)
Stock Market News(1)
Stocks On the Move(4)
Trade Postmortem(1)
Unusual Trading Activity(2)

3/27/2020 12:45 PM
A long volatility/ straddle strategy might be a good idea for the current roller-coaster market environment we're experiencing. Having a set allocation of your portfolio with these types of trades can...
12/5/2019 11:54 AM
Stocks are generally searching for direction at midday, as investors consider a muddied outlook for U.S.-China trade talks. The Dow Jones Industrial Average (DJI), S&P 500 Index (SPX), and Nasdaq...
3/20/2019 9:37 AM
The shares of SAGE Therapeutics Inc (NASDAQ:SAGE) are up 2% at $159.20, after its postpartum depression (PPD) drug, Zulresso, was approved by the Food and Drug Administration (FDA). Some experts' ne...
3/20/2019 9:21 AM
Dow Jones Industrial Average (DJI) futures are trading cautiously above fair value ahead of the final day of the Fed meeting. While next to no one is expecting an interest rate hike, investors are s...
2/15/2019 1:10 PM
Up 0.8% at $159.30, at last check, drug name SAGE Therapeutics Inc (NASDAQ:SAGE) is scheduled to report fourth-quarter earnings before the market opens on Tuesday, Feb. 19. Below, we will take a look...